|2.04||+0.01 / +0.49%|
Data as of 4:00pm ET
|2.04||+0.0004 / +0.02%|
The 4 analysts offering 12-month price forecasts for Aveo Pharmaceuticals Inc have a median target of 2.25, with a high estimate of 5.00 and a low estimate of 1.00. The median estimate represents a +10.29% increase from the last price of 2.04.
The current consensus among 6 polled investment analysts is to Hold stock in Aveo Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.